Literature DB >> 22098604

Variation and evolution of the ABC transporter genes ABCB1, ABCC1, ABCG2, ABCG5 and ABCG8: implication for pharmacogenetics and disease.

Latoya Silverton1, Michael Dean, Karobi Moitra.   

Abstract

The ATP-binding cassette (ABC) transporter genes are ubiquitous in the genomes of all vertebrates. Some of these transporters play a key role in xenobiotic defense and are endowed with the capacity to efflux harmful toxic substances. A major role in the evolution of the vertebrate ABC genes is played by gene duplication. Multiple gene duplication and deletion events have been identified in ABC genes, resulting in either gene birth or gene death indicating that the process of gene evolution is still ongoing in this group of transporters. Additionally, polymorphisms in these genes are linked to variations in expression, function, drug disposition and drug response. Single nucleotide polymorphisms in the ABC genes may be considered as markers of individual risk for adverse drug reactions or susceptibility to complex diseases as they can uniquely influence the quality and quantity of gene product. As the ABC genes continue to evolve, globalization will yield additional migration and racial admixtures that will have far reaching implications for the pharmacogenetics of this unique family of transporters in the context of human health.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22098604      PMCID: PMC7372709          DOI: 10.1515/DMDI.2011.027

Source DB:  PubMed          Journal:  Drug Metabol Drug Interact        ISSN: 0792-5077


  48 in total

1.  Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.

Authors:  Shinji Mizuarai; Naohiko Aozasa; Hidehito Kotani
Journal:  Int J Cancer       Date:  2004-03-20       Impact factor: 7.396

2.  ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.

Authors:  Takayuki Seo; Takateru Ishitsu; Nao Ueda; Naoyuki Nakada; Keigo Yurube; Kentaro Ueda; Kazuko Nakagawa
Journal:  Pharmacogenomics       Date:  2006-06       Impact factor: 2.533

3.  Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.

Authors:  Hongmei Meng; Guimei Guo; Jinyan Ren; Hui Zhou; Yubin Ge; Yingjie Guo
Journal:  Epilepsy Behav       Date:  2011-04-13       Impact factor: 2.937

Review 4.  Overview: ABC transporters and human disease.

Authors:  M M Gottesman; S V Ambudkar
Journal:  J Bioenerg Biomembr       Date:  2001-12       Impact factor: 2.945

Review 5.  Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters.

Authors:  Supratim Choudhuri; Curtis D Klaassen
Journal:  Int J Toxicol       Date:  2006 Jul-Aug       Impact factor: 2.032

6.  Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: a meta-analysis.

Authors:  Facundo Garcia Bournissen; Myla E Moretti; David N Juurlink; Gideon Koren; Mugabe Walker; Yaron Finkelstein
Journal:  Epilepsia       Date:  2008-10-24       Impact factor: 5.864

7.  Multidrug-resistant genotype (ABCB1) and seizure recurrence in newly treated epilepsy: data from international pharmacogenetic cohorts.

Authors:  Cassandra Szoeke; Graeme J Sills; Patrick Kwan; Slave Petrovski; Mark Newton; Nikolas Hitiris; Larry Baum; Samuel F Berkovic; Martin J Brodie; Leslie J Sheffield; Terence J O'Brien
Journal:  Epilepsia       Date:  2009-05-11       Impact factor: 5.864

8.  Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype.

Authors:  Alex Sparreboom; Hans Gelderblom; Sharon Marsh; Ranjeet Ahluwalia; Rosendo Obach; Paola Principe; Chris Twelves; Jaap Verweij; Howard L McLeod
Journal:  Clin Pharmacol Ther       Date:  2004-07       Impact factor: 6.875

9.  Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.

Authors:  Charis P Zamber; Jatinder K Lamba; Kazuto Yasuda; Jennifer Farnum; Kenneth Thummel; John D Schuetz; Erin G Schuetz
Journal:  Pharmacogenetics       Date:  2003-01

Review 10.  Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer.

Authors:  Zuben E Sauna; Chava Kimchi-Sarfaty; Suresh V Ambudkar; Michael M Gottesman
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

View more
  16 in total

Review 1.  Recent Advances in Application of Pharmacogenomics for Biotherapeutics.

Authors:  Pramod B Mahajan
Journal:  AAPS J       Date:  2016-03-23       Impact factor: 4.009

2.  Release of Entropic Spring Reveals Conformational Coupling Mechanism in the ABC Transporter BtuCD-F.

Authors:  Marten Prieß; Lars V Schäfer
Journal:  Biophys J       Date:  2016-06-07       Impact factor: 4.033

Review 3.  The ATP-binding cassette proteins ABCB1 and ABCC1 as modulators of glucocorticoid action.

Authors:  Kerri Devine; Elisa Villalobos; Catriona J Kyle; Ruth Andrew; Rebecca M Reynolds; Roland H Stimson; Mark Nixon; Brian R Walker
Journal:  Nat Rev Endocrinol       Date:  2022-10-11       Impact factor: 47.564

4.  Both PON1 Q192R and CYP2C19*2 influence platelet response to clopidogrel and ischemic events in Chinese patients undergoing percutaneous coronary intervention.

Authors:  Yu Chen; Xiaohong Huang; Yong Tang; Yuquan Xie; Yachen Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

5.  Mutations in intracellular loops 1 and 3 lead to misfolding of human P-glycoprotein (ABCB1) that can be rescued by cyclosporine A, which reduces its association with chaperone Hsp70.

Authors:  Khyati Kapoor; Jaya Bhatnagar; Eduardo E Chufan; Suresh V Ambudkar
Journal:  J Biol Chem       Date:  2013-09-24       Impact factor: 5.157

6.  Chromosomal-Level Genome Assembly of the Painted Sea Urchin Lytechinus pictus: A Genetically Enabled Model System for Cell Biology and Embryonic Development.

Authors:  Jacob F Warner; James W Lord; Samantha A Schreiter; Katherine T Nesbit; Amro Hamdoun; Deirdre C Lyons
Journal:  Genome Biol Evol       Date:  2021-04-05       Impact factor: 3.416

7.  Identification of trichlormethiazide as a Mdr1a/b gene expression enhancer via a dual secretion-based promoter assay.

Authors:  Sarina Schulze; Sven Reinhardt; Christian Freese; Ulrich Schmitt; Kristina Endres
Journal:  Pharmacol Res Perspect       Date:  2015-01-05

8.  High ABCG4 Expression Is Associated with Poor Prognosis in Non-Small-Cell Lung Cancer Patients Treated with Cisplatin-Based Chemotherapy.

Authors:  Guang Yang; Xue-Jiao Wang; Li-Jun Huang; Yong-An Zhou; Feng Tian; Jin-Bo Zhao; Peng Chen; Bo-Ya Liu; Miao-Miao Wen; Xiao-Fei Li; Zhi-Pei Zhang
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

Review 9.  Structural diversity of ABC transporters.

Authors:  Josy ter Beek; Albert Guskov; Dirk Jan Slotboom
Journal:  J Gen Physiol       Date:  2014-03-17       Impact factor: 4.086

10.  The repertoire of ABC proteins in Clostridioides difficile.

Authors:  Methinee Pipatthana; Phurt Harnvoravongchai; Pisut Pongchaikul; Somsak Likhitrattanapisal; Matthew Phanchana; Surang Chankhamhaengdecha; Tavan Janvilisri
Journal:  Comput Struct Biotechnol J       Date:  2021-05-08       Impact factor: 7.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.